Impact of S. aureus colonisation in human & mouse populations and relationship to vaccination by Flaxman, A

Methods for measuring T-cell memory to vaccination: from mouse to man by Flaxman, A, Ewer, K

Global distribution and prevalence of hepatitis C virus genotypes. by Messina, J, Humphreys, I, Flaxman, A, Brown, A, Cooke, G, Pybus, O, Barnes, E

Global distribution and prevalence of hepatitis C virus genotypes by Messina, J, Humphreys, I, Flaxman, A, Brown, A, Cooke, G, Pybus, O, Barnes, E

The global distribution and prevalence of HCV genotypes by Messina, J, Humphreys, I, Flaxman, A, Brown, A, Cooke, G, Pybus, O, Barnes, E

Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination by Flaxman, A, Yamaguchi, Y, Van Diemen, P, Rollier, C, Allen, E, Elshina, E, Wyllie, D

Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease by Elshina, E, Allen, E, Flaxman, A, Van Diemen, P, Milicic, A, Rollier, C, Yamaguchi, Y, Wyllie, D

Development of persistent gastrointestinal S. aureus carriage in mice by Flaxman, A, van Diemen, P, Yamaguchi, Y, Allen, E, Lindemann, C, Rollier, C, Milicic, A, Wyllie, D

A multi-filovirus vaccine candidate: Co-expression of ebola, Sudan, and Marburg antigens in a single vector by Sebastian, S, Flaxman, A, Cha, KM, Ulaszewska, M, Gilbride, C, Sharpe, H, Wright, E, Spencer, AJ, Dowall, S, Hewson, R, Gilbert, S, Lambe, T

Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study by Flaxman, A, Allen, E, Lindemann, C, Yamaguchi, Y, O'Shea, M, Fallowfield, J, Lindsay, M, Gunner, F, Knox, K, Wyllie, D

Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion by Whitehouse, J, Flaxman, A, Rollier, C, O'Shea, M, Fallowfield, J, Lindsay, M, Gunner, F, Knox, K, Wyllie, D, Yamaguchi, Y

Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS) by Butler, C, Ellis, C, Folegatti, P, Swayze, H, Allen, J, Lawrie, A, Yu, L, Shanyinde, M, Bellamy, D, Mair, C, Flaxman, A, Ewer, KJ, Gilbert, S

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination by Sharpe, HR, Provine, NM, Bowyer, GS, Moreira Folegatti, P, Belij-Rammerstorfer, S, Flaxman, A, Makinson, R, Hill, AV, Ewer, KJ, Pollard, AJ, Klenerman, P, Gilbert, S, Lambe, T

Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vi... by Cabral-Miranda, G, Heath, M, Mohsen, M, Gomes, A, Engeroff, P, Flaxman, A, Leoratti, F, El-Turabi, A, Reyes-Sandoval, A, Skinner, M, Kramer, M, Bachmann, M

Deep immune phenotyping and single-cell transcriptomics allow identification of circulating TRM-like cells which correlate with liver-stage immunity and vaccine-induced protection... by Noe, A, Datoo, M, Flaxman, A, Jenkin, D, Bellamy, D, Makinson, R, Morter, R, Ramos Lopez, F, Sheridan, J, Voukantsis, D, Prasad, N, Hill, A, Ewer, K, Spencer, A

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse by Flaxman, A, Sebastian, S, Appelberg, S, Cha, KM, Ulaszewska, M, Purushotham, J, Gilbride, C, Sharpe, H, Spencer, AJ, Bibi, S, Wright, D, Schmidt, I, Dowall, S, Easterbrook, L, Findlay-Wilson, S, Gilbert, S, Mirazimi, A, Lambe, T

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line by Folegatti, P, Bellamy, D, Flaxman, A, Mair, C, Ellis, C, Ramon, R, Lopez, F, Mitton, C, Baker, M, Poulton, I, Lawrie, A, Roberts, R, Minassian, A, Ewer, K, Evans, T, Hill, A, Gilbert, S

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies by Folegatti, P, Flaxman, A, Jenkin, D, Makinson, R, Kingham, L, Bellamy, D, Ramos Lopez, F, Sheridan, J, Poulton, I, Aboagye, J, Tran, N, Mitton, C, Roberts, R, Lawrie, A, Hill, A, Ewer, KJ, Gilbert, S

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled,... by Kulkarni, PS, Potey, AV, Bharati, S, Kunhihitlu, A, Narasimha, B, Yallapa, S, Dharmadhikari, A, Gavade, V, Kamat, CD, Mallya, A, Sarma, AD, Goel, S, Pisal, SS, Poonawalla, CS, Venkatesan, R, Jones, E, Flaxman, A, Kim, YC, Pollard, AJ

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial by Folegatti, P, Harrison, K, Preciado-Llanes, L, Ramos Lopez, F, Bittaye, M, Kim, Y, Flaxman, A, Bellamy, D, Makinson, R, Sheridan, J, Tilley, M, Tran, N, Jenkin, D, Poulton, I, Lawrie, A, Roberts, R, Berrie, E, Hill, A, Ewer, K, Reyes-Sandoval, A